ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.787,08
0,06%
S&P 500
5.509,01
0,62%
US Dollar vs BRL
5,6769
0,00%
Bitcoin
60.904,06
-1,81%
Brent Oil
86,50
0,06%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Apyx Medical Corporation (APYX)

  7. Apyx Medical Corporation (APYX) Notícias

APYX

Apyx Medical (APYX)

Apyx Medical Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:APYX
DataHoraFonteTítuloCódigoCompanhia
26/06/202408:30PR Newswire (US)Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental HealthNASDAQ:APYXApyx Medical Corporation
31/05/202415:49Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:APYXApyx Medical Corporation
09/05/202413:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APYXApyx Medical Corporation
09/05/202411:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
09/05/202408:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APYXApyx Medical Corporation
09/05/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
09/05/202408:05Business WireApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
09/05/202408:00Business WireApyx Medical Corporation Announces Board Leadership TransitionNASDAQ:APYXApyx Medical Corporation
25/04/202408:30Business WireApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:APYXApyx Medical Corporation
11/04/202408:30Business WireApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitNASDAQ:APYXApyx Medical Corporation
21/03/202408:00Business WireApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
04/03/202409:30Business WireApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024NASDAQ:APYXApyx Medical Corporation
21/02/202409:30Business WireApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingNASDAQ:APYXApyx Medical Corporation
14/02/202419:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
23/01/202411:52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APYXApyx Medical Corporation
22/01/202409:30Business WireApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyNASDAQ:APYXApyx Medical Corporation
11/01/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
08/01/202409:00Business WireApyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue ResultsNASDAQ:APYXApyx Medical Corporation
28/11/202310:30Business WireApyx Medical Corporation Appoints Matthew Hill as Chief Financial OfficerNASDAQ:APYXApyx Medical Corporation
16/11/202319:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APYXApyx Medical Corporation
09/11/202309:01Business WireApyx Medical Corporation Announces New Debt Facility with Perceptive AdvisorsNASDAQ:APYXApyx Medical Corporation
09/11/202309:00Business WireApyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
07/11/202309:30Business WireApyx Medical Corporation to Participate in Upcoming Investor Conferences in NovemberNASDAQ:APYXApyx Medical Corporation
02/10/202308:30Business WireApyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:APYXApyx Medical Corporation
10/08/202317:05Business WireApyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
29/06/202317:42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APYXApyx Medical Corporation
29/06/202317:42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:APYXApyx Medical Corporation
29/06/202317:05Business WireApyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023NASDAQ:APYXApyx Medical Corporation
28/06/202315:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APYXApyx Medical Corporation
21/06/202311:54Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:APYXApyx Medical Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:APYX

Seu Histórico Recente

BIT
P1X2D4
NLBNPIT1X2D4 20351221 13...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados